Organon & Co. (OGN) Probability Analysis

Probability analysis extracts the risk-neutral probability distribution implied by option prices. It shows the market-implied likelihood of the underlying reaching various price levels by expiration.

Organon & Co. (OGN) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $3.51B, listed on NYSE, employing roughly 10,000 people, carrying a beta of 1.55 to the broader market. Organon & Co. Led by Joseph T. Morrissey Jr., public since 2021-05-14.

Snapshot as of May 29, 2026.

Spot Price
$13.38
ATM IV
2.1%
IV Rank
0.2%
IV Percentile
0.8%
HV 20-Day
4.7%
IV Skew 25Δ
0.034

As of May 29, 2026, Organon & Co. (OGN) at $13.38 has an ATM IV of 2.1%, implying a 30-day one-standard-deviation range of approximately ±$0.08. IV rank is 0.2% (subdued, distribution priced tighter than usual). IV percentile is 0.8%. The 25-delta skew is +0.034: upside tail priced richer than downside, biasing probability mass above spot. Under lognormal assumptions roughly 68% of outcomes fall within ±1σ and 95% within ±2σ; risk-neutral probability analysis refines this by extracting the market-implied distribution directly from options prices, capturing the fat tails that real markets exhibit.

How OGN probability analysis Data Feeds Strategy Selection

Strategy selection on Organon & Co. options does not derive from any single metric in isolation. The probability analysis view above sits inside a broader read: ATM IV currently sits at 2.1% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the probability analysis data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

How to read the OGN probability distribution

The probability cone above is the option-market-implied distribution of where Organon & Co. spot could end up at expiration. It's derived from the implied-volatility surface via a risk-neutral pricing transformation, not from historical realized returns. With ATM IV at 2.1% and spot at $13.38, the 1σ band is approximately ±0.7% over a 30-day horizon. Recent realized HV-20 of 4.7% runs 2.6 vol points above current implied, an inverted regime where premium buyers are underpaying.

OGN risk-neutral vs real-world probabilities

The probabilities derived from option prices reflect the market's risk-adjusted view, not the realized statistical distribution. Risk-neutral probabilities include the equity risk premium and skew preferences priced into options, so they tend to overstate tail probability and understate upside drift relative to actually-realized outcomes. For probability-of-touch calculations and assignment-risk modeling, risk-neutral is the right benchmark. For position-sizing your own conviction, blend with realized-volatility-based statistics from the HV columns.

Trading the OGN distribution

Probability-driven strategies aim to capture mispricings between the implied distribution and your own probability assessment. Premium-selling structures (credit spreads, iron condors, cash-secured puts) profit when the implied distribution overprices tail probability relative to realized; premium-buying (debit spreads, long calls/puts, long straddles) profits in the reverse. With OGN IV rank at 0.2%, the chain is pricing tighter tails than recent realized history; buyers get cheaper optionality but need a real catalyst to monetize. Always pair probability-driven strategy selection with a stop loss or wing-defined risk - the implied distribution is a snapshot, and regime shifts can invalidate it intraday.

Learn how risk-neutral density is reported and how to read the data →

Frequently asked OGN probability analysis questions

What is the OGN 30-day expected price range?
As of May 29, 2026, with OGN at $13.38 and ATM IV at 2.1%, the implied 30-day one-standard-deviation range is approximately ±$0.08, or about $13.30 to $13.46. IV rank is subdued, so the priced distribution is tighter than the 1-year typical width.
What does OGN risk-neutral density tell us?
Risk-neutral density is the probability distribution of future OGN price implied by listed option prices. Extracted via Breeden-Litzenberger (twice-differentiating the call price function with respect to strike), it represents the pricing kernel rather than the real-world probability of outcomes. Persistent skew or fat-tail features in the density reflect how the market is pricing tail risk.
How does OGN ATM IV translate to a probability range?
ATM IV is annualized; multiplying by sqrt(t/365) scales it to the chosen tenor. Under lognormal assumptions, the resulting standard deviation defines the ±1σ band that contains roughly 68% of outcomes, ±2σ for 95%. Empirical equity returns have fatter tails than log-normal, so the implied tail probabilities under-state realized tail frequency in stressed regimes.